During the progression of AD, AChE levels in the brain were substantially reduced to 10%, while BChE increased to 165% of normal levels, functionalizing the compensation capacity of the latter for acetylcholine hydrolysis (Perry et al., 1978; Ballard et al., 2005). The gene discussed is ACHE; the disease is Alzheimer disease.